Select a section from the left sidebar
(22R,25R)-3beta-spirost-5-ene-3-O-beta-D-glucopyranosyl(1→2)-O-alpha-L-rhamnopyranoside
- Family: Plantae - Arecaceae
- Kingdom: Plantae
-
Class: Saponin
- Subclass: Steroidal Saponin
| Canonical Smiles | C1[C@@H](CC2=CCC3C([C@]2(C1)C)CC[C@]1(C3CC2C1[C@@H]([C@@]1(O2)OCC(CC1)C)C)C)O[C@H]1C([C@H]([C@@H](C(O1)CO)O)O)O[C@H]1C([C@H]([C@H](C(O1)C)O)O)O |
|---|---|
| InChI | InChI=1S/C39H62O12/c1-18-8-13-39(46-17-18)19(2)28-26(51-39)15-25-23-7-6-21-14-22(9-11-37(21,4)24(23)10-12-38(25,28)5)48-36-34(32(44)30(42)27(16-40)49-36)50-35-33(45)31(43)29(41)20(3)47-35/h6,18-20,22-36,40-45H,7-17H2,1-5H3/t18?,19-,20?,22-,23?,24?,25?,26?,27?,28?,29-,30+,31-,32-,33?,34?,35-,36+,37-,38-,39+/m0/s1 |
| InChIKey | HDXIQHTUNGFJIC-MPOPHWNUSA-N |
| Formula | C39H62O12 |
| HBA | 12 |
| HBD | 6 |
| MW | 722.91 |
| Rotatable Bonds | 5 |
| TPSA | 176.76 |
| LogP | 2.39 |
| Number Rings | 8 |
| Number Aromatic Rings | 0 |
| Heavy Atom Count | 51 |
| Formal Charge | 0 |
| Fraction CSP3 | 0.95 |
| Exact Mass | 722.42 |
| Number of Lipinski Rule Violations | 3 |
| # | Species | Family | Kingdom | NCBI Taxonomy ID |
|---|---|---|---|---|
| 1 | Raphia vinifera | Arecaceae | Plantae | 1966430 |
Showing of synonyms
(22R,25R)-3beta-spirost-5-ene-3-O-beta-D-glucopyranosyl(1→2)-O-alpha-L-rhamnopyranoside
No compound-protein relationship available.
SMILES: O1CCCCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CC(CC6)OC(OCCC7)C7OC8CCCCO8
Level: 2
Mol. Weight: 722.91 g/mol
SMILES: O1CCCCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CC(CC6)OC7CCCCO7
Level: 1
Mol. Weight: 722.91 g/mol
SMILES: C1OCCCC1OC2CCCCO2
Level: 1
Mol. Weight: 722.91 g/mol
SMILES: O1CCCCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CCCC6
Level: 0
Mol. Weight: 722.91 g/mol
SMILES: C1CCOCC1
Level: 0
Mol. Weight: 722.91 g/mol
Anticancer
Absorption
- Caco-2 (logPapp)
- -6.21
- Human Oral Bioavailability 20%
- Bioavailable
- Human Intestinal Absorption
- Absorbed
- Madin-Darby Canine Kidney
- 0.62
- Human Oral Bioavailability 50%
- Bioavailable
- P-Glycoprotein Inhibitor
- Inhibitor
- P-Glycoprotein Substrate
- Non-Substrate
- Skin Permeability
- 818.17
Distribution
- Blood-Brain Barrier (CNS)
- -
- Blood-Brain Barrier
- Non-Penetrable
- Fraction Unbound (Human)
- 0.88
- Plasma Protein Binding
- 81.06
- Steady State Volume of Distribution
- -
Metabolism
- Breast Cancer Resistance Protein
- Non-Inhibitor
- CYP 1A2 Inhibitor
- Non-Inhibitor
- CYP 1A2 Substrate
- Non-Substrate
- CYP 2C19 Inhibitor
- Non-Inhibitor
- CYP 2C19 Substrate
- Substrate
- CYP 2C9 Inhibitor
- Non-Inhibitor
- CYP 2C9 Substrate
- Non-Substrate
- CYP 2D6 Inhibitor
- Non-Inhibitor
- CYP 2D6 Substrate
- Non-Substrate
- CYP 3A4 Inhibitor
- Non-Inhibitor
- CYP 3A4 Substrate
- Substrate
- OATP1B1
- Non-Inhibitor
- OATP1B3
- Non-Inhibitor
Excretion
- Clearance
- 0.72
- Organic Cation Transporter 2
- Non-Inhibitor
- Half-Life of Drug
- -
Toxicity
- AMES Mutagenesis
- Safe
- Avian
- Safe
- Bee
- Toxic
- Bioconcentration Factor
- -18.98
- Biodegradation
- Safe
- Carcinogenesis
- Safe
- Crustacean
- Safe
- Liver Injury I (DILI)
- Toxic
- Eye Corrosion
- Safe
- Eye Irritation
- Safe
- Maximum Tolerated Dose
- -1.4
- Liver Injury II
- Safe
- hERG Blockers
- Safe
- Daphnia Maga
- 7.07
- Micronucleos
- Safe
- NR-AhR
- Safe
- NR-AR
- Safe
- NR-AR-LBD
- Safe
- NR-Aromatase
- Toxic
- NR-ER
- Safe
- NR-ER-LBD
- Safe
- NR-GR
- Safe
- NR-PPAR-gamma
- Safe
- NR-TR
- Safe
- T. Pyriformis
- -1485701.02
- Rat (Acute)
- 3.56
- Rat (Chronic Oral)
- 3.79
- Fathead Minnow
- 1882.19
- Respiratory Disease
- Toxic
- Skin Sensitisation
- Safe
- SR-ARE
- Safe
- SR-ATAD5
- Safe
- SR-HSE
- Safe
- SR-MMP
- Toxic
- SR-p53
- Safe
General Properties
- Boiling Point
- 164703.66
- Hydration Free Energy
- -2.92
- Log(D) at pH=7.4
- 4.53
- Log(P)
- 3.62
- Log S
- -3.55
- Log(Vapor Pressure)
- -5328.12
- Melting Point
- 220.05
- pKa Acid
- -5.87
- pKa Basic
- 5.73